Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefoxitin PK in major abdominal surgery
NCT02703857Phase 4Completed
- Sponsor
- CHU de Poitiers
- Start
- Feb 2016
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of cefoxitin in surgical site infection (SSI), sponsored by CHU de Poitiers. Primary endpoints: Total and free plasma concentrations of cefoxitin, Free tissue concentrations of cefoxitin and 1 more. Started Feb 2016; status: completed.
02
Drugs
cefoxitin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT02703857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02703857.